Inactivation of the riboswitch-controlled GMP synthase GuaA in Clostridioides difficile is associated with severe growth defects and poor infectivity in a mouse model of infection

References

• Guery B, Galperine T, Barbut F. Clostridioides difficile: diagnosis and treatments. British Med J. 2019;366:l4609.
   PubMed Web of Science ®Google Scholar
• Cho JM, Pardi DS, Khanna S. Update on Treatment of Clostridioides difficile Infection. Mayo Clin Proc. 2020;95:758–769.
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Enns EA, Khoruts A, et al. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: an Evaluation of the 2018 Infectious Diseases Society of America Guidelines. Clin Infect Dis. 2019;70:754–762.
   Web of Science ®Google Scholar
• Lünse CE, Schüller A, Mayer G. The promise of riboswitches as potential antibacterial drug targets. Int J Med Microbiol. 2014;304:79–92.
   PubMed Web of Science ®Google Scholar
• Blount KF, Breaker RR. Riboswitches as antibacterial drug targets. Nat Biotechnol. 2006;24:1558–1564.
   PubMed Web of Science ®Google Scholar
• Sudarsan N, Barrick JE, Breaker RR. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA. 2003;9:644–647.
   PubMed Web of Science ®Google Scholar
• Greenlee EB, Stav S, Atilho RM, et al. Challenges of ligand identification for the second wave of orphan riboswitch candidates. RNA Biol. 2018;15
   PubMed Web of Science ®Google Scholar
• Weinberg Z, Lünse CE, Corbino KA, et al. Detection of 224 candidate structured RNAs by comparative analysis of specific subsets of intergenic regions. Nucleic Acids Res. 2017;45:10811–10823.
   PubMed Web of Science ®Google Scholar
• Serganov A, Nudler E. A Decade of Riboswitches. Cell. 2013;152:17–24.
   PubMed Web of Science ®Google Scholar
• McCown PJ, Corbino KA, Stav S, et al. Riboswitch diversity and distribution. RNA. 2017;23:995–1011.
   PubMed Web of Science ®Google Scholar
• Bastet L, Dubé A, Massé E, et al. New insights into riboswitch regulation mechanisms. Mol Microbiol. 2011;80:1148–1154.
   PubMed Web of Science ®Google Scholar
• Hall CL, Lee VT. Cyclic‐di‐GMP regulation of virulence in bacterial pathogens. Wiley Interdiscip Rev RNA. 2018;9:e1454.
   Web of Science ®Google Scholar
• Christiansen LC, Schou S, Nygaard P, et al. Xanthine metabolism in Bacillus subtilis: characterization of the xpt-pbuX operon and evidence for purine- and nitrogen-controlled expression of genes involved in xanthine salvage and catabolism. J Bacteriol. 1997;179:2540–2550.
   PubMed Web of Science ®Google Scholar
• Ebbole DJ, Zalkin H. Cloning and characterization of a 12-gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis. J Biological Chem. 1987;262:8274–8287.
   PubMed Web of Science ®Google Scholar
• Xi H, Schneider BL, Reitzer L. Purine Catabolism in Escherichia coli and Function of Xanthine Dehydrogenase in Purine Salvage. J Bacteriol. 2000;182:5332–5341.
   PubMed Web of Science ®Google Scholar
• Mäntsälä P, Zalkin H. Cloning and sequence of Bacillus subtilis purA and guaA, involved in the conversion of IMP to AMP and GMP. J Bacteriol. 1992;174:1883–1890.
   PubMedGoogle Scholar
• Shimaoka M, Takenaka Y, Mihara Y, et al. Effects of xapA and guaA Disruption on Inosine Accumulation in Escherichia coli. Biosci Biotechnol Biochem. 2014;70:3069–3072.
   Google Scholar
• Kotloff KL, Pasetti MF, Barry EM, Nataro JP, Wasserman SS, Sztein MB, Picking WD, Levine MM. Deletion in the Shigella Enterotoxin Genes Further Attenuates Shigella flexneri 2a Bearing Guanine Auxotrophy in a Phase 1 Trial of CVD 1204 and CVD 1208. J Infect Dis. 2004;190:1745–1754.
   PubMed Web of Science ®Google Scholar
• Kofoed EM, Yan D, Katakam AK, et al. De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In Vivo. J Bacteriol. 2016;198:2001–2015.
   PubMed Web of Science ®Google Scholar
• Mandal M, Boese B, Barrick JE, et al. Riboswitches Control Fundamental Biochemical Pathways in Bacillus subtilis and Other Bacteria. Cell. 2003;113:577–586.
   PubMed Web of Science ®Google Scholar
• Mulhbacher J, Brouillette E, Allard M, et al. Novel Riboswitch Ligand Analogs as Selective Inhibitors of Guanine-Related Metabolic Pathways. Plos Pathog. 2010;6:e1000865.
   PubMed Web of Science ®Google Scholar
• Regulski EE, Breaker RR. In-line probing analysis of riboswitches. In: Wilusz J, editor. Post-Transcriptional Gene Regulation. Methods Mol Biol. Vol. 419. Humana Press; 2008. p. 53–67.
   Google Scholar
• Fagan RP, Fairweather NF. Clostridium difficile Has Two Parallel and Essential Sec Secretion Systems*. J Biol Chem. 2011;286:27483–27493.
   PubMed Web of Science ®Google Scholar
• Heap JT, Pennington OJ, Cartman ST, et al. The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods. 2007;70:452–464.
   PubMed Web of Science ®Google Scholar
• Karlsson S, Burman LG, Åkerlund T. Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology+. 1999;145:1683–1693.
   PubMed Web of Science ®Google Scholar
• Ster C, Allard M, Boulanger S, et al. Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog. J Dairy Sci. 2013;96:1000–1008.
   PubMed Web of Science ®Google Scholar
• McFarland WC, Stocker BAD. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microbiol Pathogen. 1987;3:129–141.
   PubMed Web of Science ®Google Scholar
• Russo TA, Jodush ST, Brown JJ, et al. Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol. 1996;22:217–229.
   PubMed Web of Science ®Google Scholar
• Stoddard CD, Widmann J, Trausch JJ, et al. Nucleotides Adjacent to the Ligand-Binding Pocket are Linked to Activity Tuning in the Purine Riboswitch. J Mol Biol. 2013;425:1596–1611.
   PubMed Web of Science ®Google Scholar
• Winkler W, Nahvi A, Breaker RR. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature. 2002;419:952–956.
   PubMed Web of Science ®Google Scholar
• Chauvier A, Picard-Jean F, J-c B-D, et al. Transcriptional pausing at the translation start site operates as a critical checkpoint for riboswitch regulation. Nat Commun. 2017;8:13892.
   PubMed Web of Science ®Google Scholar
• Wickiser JK, Winkler WC, Breaker RR, et al. The Speed of RNA Transcription and Metabolite Binding Kinetics Operate an FMN Riboswitch. Mol Cell. 2005;18:49–60.
   PubMed Web of Science ®Google Scholar
• Wickiser JK, Cheah MT, Breaker RR, et al. The Kinetics of Ligand Binding by an Adenine-Sensing Riboswitch. Biochemistry-US. 2005;44:13404–13414.
   PubMed Web of Science ®Google Scholar
• Daou N, Wang Y, Levdikov VM, et al. Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027. Plos One. 2019;14:e0206896.
   PubMed Web of Science ®Google Scholar
• Dineen SS, McBride SM, Sonenshein AL. Integration of Metabolism and Virulence by Clostridium difficile CodY. J Bacteriol. 2010;192:5350–5362.
   PubMed Web of Science ®Google Scholar
• Nawrocki KL, Edwards AN, Daou N, et al. CodY-Dependent Regulation of Sporulation in Clostridium difficile. J Bacteriol. 2016;198:2113–2130.
   PubMed Web of Science ®Google Scholar
• Sekulovic O, Fortier L-C. Global Transcriptional Response of Clostridium difficile Carrying the ϕCD38-2 Prophage. Appl Environ Microb. 2015;81:1364–1374.
   PubMed Web of Science ®Google Scholar
• Mulhbacher J, Lafontaine DA. Ligand recognition determinants of guanine riboswitches. Nucleic Acids Res. 2007;35:5568–5580.
   PubMed Web of Science ®Google Scholar
• Heap JT, Pennington OJ, Cartman ST, et al. A modular system for Clostridium shuttle plasmids. J Microbiol Methods. 2009;78:79–85.
   PubMed Web of Science ®Google Scholar
• Mani N, Lyras D, Barroso L, et al. Environmental Response and Autoregulation of Clostridium difficile TxeR, a Sigma Factor for Toxin Gene Expression. J Bacteriol. 2002;184:5971–5978.
   PubMed Web of Science ®Google Scholar
• Garneau JR, Valiquette L, Fortier L-C. Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC Infect Dis. 2014;14:29.
   PubMed Web of Science ®Google Scholar